IL156998A0 - New film coating - Google Patents

New film coating

Info

Publication number
IL156998A0
IL156998A0 IL15699802A IL15699802A IL156998A0 IL 156998 A0 IL156998 A0 IL 156998A0 IL 15699802 A IL15699802 A IL 15699802A IL 15699802 A IL15699802 A IL 15699802A IL 156998 A0 IL156998 A0 IL 156998A0
Authority
IL
Israel
Prior art keywords
film coating
new film
pharmaceutical formulations
modified release
film
Prior art date
Application number
IL15699802A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0104327A external-priority patent/SE0104327D0/xx
Priority claimed from SE0104328A external-priority patent/SE0104328D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL156998A0 publication Critical patent/IL156998A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Piezo-Electric Transducers For Audible Bands (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IL15699802A 2001-12-19 2002-12-18 New film coating IL156998A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0104327A SE0104327D0 (sv) 2001-12-19 2001-12-19 New film coating
SE0104328A SE0104328D0 (sv) 2001-12-19 2001-12-19 New film coating
PCT/GB2002/005739 WO2003051340A1 (fr) 2001-12-19 2002-12-18 Nouvelle pellicule

Publications (1)

Publication Number Publication Date
IL156998A0 true IL156998A0 (en) 2004-02-08

Family

ID=26655630

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15699802A IL156998A0 (en) 2001-12-19 2002-12-18 New film coating

Country Status (25)

Country Link
US (2) US6827947B2 (fr)
EP (2) EP1355633B1 (fr)
JP (1) JP2005514386A (fr)
KR (1) KR20040065989A (fr)
CN (1) CN100341491C (fr)
AT (1) ATE287259T1 (fr)
AU (2) AU2002361447B2 (fr)
BR (1) BR0206441A (fr)
CA (1) CA2435729C (fr)
CZ (1) CZ20031970A3 (fr)
DE (2) DE20220902U1 (fr)
DK (1) DK1355633T3 (fr)
ES (1) ES2233876T3 (fr)
HU (1) HUP0303886A3 (fr)
IL (1) IL156998A0 (fr)
IS (1) IS6863A (fr)
MX (1) MXPA03007156A (fr)
NO (1) NO320358B1 (fr)
NZ (1) NZ526926A (fr)
PL (1) PL362378A1 (fr)
PT (1) PT1355633E (fr)
RU (1) RU2323717C2 (fr)
SI (1) SI1355633T1 (fr)
SK (1) SK9132003A3 (fr)
WO (1) WO2003051340A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (fr) * 2001-12-19 2005-01-19 AstraZeneca AB NOUVELLE PELLICULE contenant un copolymère acrylate d'éthyle/méthacrylate de méthyle et un acétate de polyvinyle
CA2476201C (fr) 2002-02-21 2009-09-01 Biovail Laboratories Incorporated Formulations a liberation modifiee d'au moins une forme de tramadol
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
US7080545B2 (en) * 2002-10-17 2006-07-25 Advanced Technology Materials, Inc. Apparatus and process for sensing fluoro species in semiconductor processing systems
NZ547284A (en) * 2003-10-31 2009-12-24 Hexal Ag Pharmaceutical agent-containing formulation comprising a coating of a film forming polymer
WO2005084636A2 (fr) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited Procede de preparation d'une composition pharmaceutique a liberation controlee de metoprolol
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004035936A1 (de) * 2004-07-23 2006-03-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
US20070048371A1 (en) * 2005-07-28 2007-03-01 Shojaei Amir H Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
US8231902B2 (en) * 2005-11-18 2012-07-31 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
DE102005060393A1 (de) * 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
EP2461811B1 (fr) 2009-08-05 2016-04-20 Idenix Pharmaceuticals LLC. Inhibiteurs macrocycliques de la sérine protéase macrocyclique utiles contre les infections virales, en particulier le virus de l'hépatite c
WO2011056764A1 (fr) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Imidazo[2,1-b][1,3]benzothiazoles enrichis en isotopes ou fluores
KR20120118008A (ko) 2009-12-18 2012-10-25 아이데닉스 파마슈티칼스, 인코포레이티드 5,5-융합 아릴렌 또는 헤테로아릴렌 간염 ｃ 바이러스 억제제
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
WO2011094890A1 (fr) 2010-02-02 2011-08-11 Argusina Inc. Dérivés phénylalanines et leur utilisation comme modulateurs non peptidiques du récepteur de glp-1
WO2011112689A2 (fr) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Sels d'indazolylpyrrolotriazine
ES2579942T3 (es) 2010-09-01 2016-08-17 Ambit Biosciences Corporation Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma
CN103270030B (zh) 2010-09-01 2016-01-20 埃姆比特生物科学公司 吡唑基氨基喹唑啉的氢溴酸盐
EP2648676A4 (fr) 2010-12-06 2016-05-04 Follica Inc Procédés destinés à traiter la calvitie et à favoriser la croissance des cheveux
WO2012080050A1 (fr) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Formes solides d'un composé de phénoxybenzènesulfonyle
WO2012106299A1 (fr) 2011-01-31 2012-08-09 Celgene Corporation Compositions pharmaceutiques d'analogues de cytidine et leurs méthodes d'utilisation
AR085352A1 (es) 2011-02-10 2013-09-25 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
BR112013027484A8 (pt) * 2011-06-17 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato
AU2011370762A1 (en) * 2011-06-17 2013-11-14 Evonik Rohm Gmbh Coating composition suitable for pharmaceutical or nutraceutical dosage forms
KR20140138293A (ko) 2012-03-16 2014-12-03 액시킨 파마수티컬스 인코포레이티드 3,5-다이아미노피라졸 키나아제 억제제
BR112015018895A2 (pt) 2013-02-13 2017-07-18 Evonik Roehm Gmbh composição farmacêutica multiparticulada compreendendo uma multiplicidade de dois tipos de pelotas
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (fr) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Inhibiteurs du virus de l'hépatite c
JP5846185B2 (ja) 2013-11-21 2016-01-20 大日本印刷株式会社 貫通電極基板及び貫通電極基板を用いた半導体装置
US20170066779A1 (en) 2014-03-05 2017-03-09 Idenix Pharmaceuticals Llc Solid forms of a flaviviridae virus inhibitor compound and salts thereof
KR102409739B1 (ko) 2014-03-20 2022-06-17 카펠라 테라퓨틱스, 인크. 암 치료용의 ｅｒｂｂ 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
KR102416358B1 (ko) 2014-03-20 2022-07-07 카펠라 테라퓨틱스, 인크. 암 치료용의 ｅｒｂｂ 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
MX2017000384A (es) * 2014-07-09 2017-04-27 Sun Pharmaceutical Ind Ltd Forma de dosificacion en capsulas de succinato de metoprolol.
WO2016042565A1 (fr) * 2014-09-16 2016-03-24 Suresh Pareek Formulation à libération prolongée de métoprolol
US9546163B2 (en) 2014-12-23 2017-01-17 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
SG11201811579VA (en) * 2016-06-30 2019-01-30 Beckman Coulter Inc Chemiluminescent substrates
ES3040411T3 (en) 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4916171A (en) 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
SE450087B (sv) 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5246714A (en) 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
US4975283A (en) 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
GB9200607D0 (en) 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
ATE195252T1 (de) 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
CA2117546A1 (fr) * 1993-08-27 1995-02-28 Takateru Muraoka Feuille adhesive a usage medical
DE4444051A1 (de) 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5871776A (en) 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (fr) * 2001-12-19 2005-01-19 AstraZeneca AB NOUVELLE PELLICULE contenant un copolymère acrylate d'éthyle/méthacrylate de méthyle et un acétate de polyvinyle
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
ATE287259T1 (de) 2005-02-15
HUP0303886A2 (hu) 2004-05-28
SK9132003A3 (en) 2004-02-03
CZ20031970A3 (cs) 2003-10-15
JP2005514386A (ja) 2005-05-19
NO320358B1 (no) 2005-11-28
NO20033653D0 (no) 2003-08-18
PT1355633E (pt) 2005-05-31
AU2002361447A1 (en) 2003-06-30
MXPA03007156A (es) 2003-11-18
HUP0303886A3 (en) 2005-05-30
CA2435729A1 (fr) 2003-06-26
AU2008207594A1 (en) 2008-09-18
EP1355633A1 (fr) 2003-10-29
ES2233876T3 (es) 2005-06-16
DE20220902U1 (de) 2004-06-09
IS6863A (is) 2003-07-01
EP1355633B1 (fr) 2005-01-19
RU2003125371A (ru) 2005-02-10
US20040030033A1 (en) 2004-02-12
NZ526926A (en) 2006-02-24
BR0206441A (pt) 2003-12-30
AU2002361447B2 (en) 2008-05-29
DE60202662D1 (de) 2005-02-24
CN1503663A (zh) 2004-06-09
EP1477163A1 (fr) 2004-11-17
SI1355633T1 (en) 2005-06-30
DK1355633T3 (da) 2005-04-04
DE60202662T2 (de) 2006-01-05
US6827947B2 (en) 2004-12-07
PL362378A1 (en) 2004-10-18
US7815938B2 (en) 2010-10-19
WO2003051340A1 (fr) 2003-06-26
US20050089574A1 (en) 2005-04-28
KR20040065989A (ko) 2004-07-23
CN100341491C (zh) 2007-10-10
RU2323717C2 (ru) 2008-05-10
NO20033653L (no) 2003-10-10
HK1058312A1 (en) 2004-05-14
CA2435729C (fr) 2005-12-13

Similar Documents

Publication Publication Date Title
IL156998A0 (en) New film coating
NZ526792A (en) Film coating composition for controlled release from pharmaceutical formulations
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
AU2003216849A1 (en) A marking apparatus for nucleic acid marking of items
WO2005063231A3 (fr) Formulation contenant un acide carboxylique ou un ester de celui-ci
GR3023383T3 (en) Pharmaceutical preparations based on gastrointestinal mucosa-adherent matrixes or coatings
ATE295155T1 (de) Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
DE69636724D1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
AU2003274680A1 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2009028583A1 (fr) Procédé pour produire une préparation revêtue
CA2530380A1 (fr) Compositions de revetement intumescentes
DK1169032T3 (da) Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
GB1296241A (fr)
ATE423179T1 (de) Amphiphile copolymerzusammensetzungen
AU2003276641A1 (en) Coating composition having polyvinyl chloride extender particles
TW200615692A (en) Radiation sensitive composition and method for the preparation of the same
WO2003070833A3 (fr) Compositions durcissables par rayonnement contenant des copolymeres alternes de monomeres du type isobutylene
EP1435370A4 (fr) Composition de matiere de revetement
WO2004048425A3 (fr) Copolymeres superabsorbants polyamphoteres
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
SE0202353D0 (sv) New film coating
BR0111504A (pt) Composições dilatáveis em água
SE0104327D0 (sv) New film coating
WO2003087180A3 (fr) Pelliculage nouveau
CA2036402A1 (fr) Laque aerosol capillaire contenant un tetrapolymere d'acide acrylique, de n,n-dimethylacrylamide, de n-tertiobutylacrylamide et de methacrylate d'ethyle et un gaz propulseur non halogene